The Patient Perspective on… immunotherapy advancements

Immunotherapy is the hot topic of oncology research in the last few years.  As this timeline of immunotherapy highlights, discoveries and treatments dotted the landscape sporadically until early this decade, when the anti-CTLA-4 antibody ipilimumab (Yervoy®) kick-started a wave of immunotherapy innovations.  The latest approvals show that existing immunotherapy drugs are effective on a number of traditional cancer types. Further, combination therapies continue to show promise and other novel checkpoint inhibitors lead the field into an ever-increasing number of possible treatments. "Digging a little deeper, though, the true value of this research becomes evident..." Recently, an extremely high response rate for a...